| Hans-Günter Meyer-Thompson | Hepatitiden
A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs.
A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs.
Yi S, Truong D, Conway B.
J Virus Erad. 2024 Aug 31;10(3):100388. doi: 10.1016/j.jve.2024.100388. PMID: 39319041; PMCID: PMC11420441.